151 related articles for article (PubMed ID: 20680840)
1. Engineered zinc finger proteins for manipulation of the human mitochondrial genome.
Minczuk M
Methods Mol Biol; 2010; 649():257-70. PubMed ID: 20680840
[TBL] [Abstract][Full Text] [Related]
2. Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA.
Minczuk M; Kolasinska-Zwierz P; Murphy MP; Papworth MA
Nat Protoc; 2010 Feb; 5(2):342-56. PubMed ID: 20134433
[TBL] [Abstract][Full Text] [Related]
3. [Progress in zinc finger nuclease engineering for targeted genome modification].
Xiao A; Hu YY; Wang WY; Yang ZP; Wang ZX; Huang P; Tong XJ; Zhang B; Lin S
Yi Chuan; 2011 Jul; 33(7):665-83. PubMed ID: 22049679
[TBL] [Abstract][Full Text] [Related]
4. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.
Rai PK; Craven L; Hoogewijs K; Russell OM; Lightowlers RN
Essays Biochem; 2018 Jul; 62(3):455-465. PubMed ID: 29950320
[TBL] [Abstract][Full Text] [Related]
5. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
Minczuk M; Papworth MA; Miller JC; Murphy MP; Klug A
Nucleic Acids Res; 2008 Jul; 36(12):3926-38. PubMed ID: 18511461
[TBL] [Abstract][Full Text] [Related]
6. The use of mitochondria-targeted endonucleases to manipulate mtDNA.
Bacman SR; Williams SL; Pinto M; Moraes CT
Methods Enzymol; 2014; 547():373-97. PubMed ID: 25416366
[TBL] [Abstract][Full Text] [Related]
7. Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.
Gammage PA; Van Haute L; Minczuk M
Methods Mol Biol; 2016; 1351():145-62. PubMed ID: 26530680
[TBL] [Abstract][Full Text] [Related]
8. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA).
Sander JD; Dahlborg EJ; Goodwin MJ; Cade L; Zhang F; Cifuentes D; Curtin SJ; Blackburn JS; Thibodeau-Beganny S; Qi Y; Pierick CJ; Hoffman E; Maeder ML; Khayter C; Reyon D; Dobbs D; Langenau DM; Stupar RM; Giraldez AJ; Voytas DF; Peterson RT; Yeh JR; Joung JK
Nat Methods; 2011 Jan; 8(1):67-9. PubMed ID: 21151135
[TBL] [Abstract][Full Text] [Related]
9. Synthetic zinc finger nuclease design and rapid assembly.
Osborn MJ; DeFeo AP; Blazar BR; Tolar J
Hum Gene Ther; 2011 Sep; 22(9):1155-65. PubMed ID: 21663559
[TBL] [Abstract][Full Text] [Related]
10. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN).
Foley JE; Yeh JR; Maeder ML; Reyon D; Sander JD; Peterson RT; Joung JK
PLoS One; 2009; 4(2):e4348. PubMed ID: 19198653
[TBL] [Abstract][Full Text] [Related]
11. Progress and prospects: zinc-finger nucleases as gene therapy agents.
Carroll D
Gene Ther; 2008 Nov; 15(22):1463-8. PubMed ID: 18784746
[TBL] [Abstract][Full Text] [Related]
12. Biological and biomedical applications of engineered nucleases.
Pan Y; Xiao L; Li AS; Zhang X; Sirois P; Zhang J; Li K
Mol Biotechnol; 2013 Sep; 55(1):54-62. PubMed ID: 23089945
[TBL] [Abstract][Full Text] [Related]
13. Zinc fingers hit off target.
Cheng L; Blazar B; High K; Porteus M
Nat Med; 2011 Oct; 17(10):1192-3. PubMed ID: 21988995
[No Abstract] [Full Text] [Related]
14. Repeatable construction method for engineered zinc finger nuclease based on overlap extension PCR and TA-cloning.
Fujii W; Kano K; Sugiura K; Naito K
PLoS One; 2013; 8(3):e59801. PubMed ID: 23536890
[TBL] [Abstract][Full Text] [Related]
15. Molecular scissors for in situ cellular repair.
Prieto J; Molina R; Montoya G
Crit Rev Biochem Mol Biol; 2012; 47(3):207-21. PubMed ID: 22283548
[TBL] [Abstract][Full Text] [Related]
16. Progress and prospects: gene therapy for mitochondrial DNA disease.
Kyriakouli DS; Boesch P; Taylor RW; Lightowlers RN
Gene Ther; 2008 Jul; 15(14):1017-23. PubMed ID: 18496570
[TBL] [Abstract][Full Text] [Related]
17. Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases.
Straimer J; Lee MC; Lee AH; Zeitler B; Williams AE; Pearl JR; Zhang L; Rebar EJ; Gregory PD; Llinás M; Urnov FD; Fidock DA
Nat Methods; 2012 Oct; 9(10):993-8. PubMed ID: 22922501
[TBL] [Abstract][Full Text] [Related]
18. A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells.
Moraes CT
EMBO Mol Med; 2014 Apr; 6(4):434-5. PubMed ID: 24623377
[TBL] [Abstract][Full Text] [Related]
19. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger nuclease technology: advances and obstacles in modelling and treating genetic disorders.
Jabalameli HR; Zahednasab H; Karimi-Moghaddam A; Jabalameli MR
Gene; 2015 Mar; 558(1):1-5. PubMed ID: 25536166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
